Aspirin inhibition of n-[4-(5-nitro-2-fury1)-2-thiazolyl]formamideinduced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase

Cancer Research

Volumn 41, Issue , 1981, Pages 3355-3359

  Cohen, Samuel M ^a   Fukushima, Shoji ^a   Murasaki, Gen’i ^a   Zenser, Terry V ^b   Mattammal, Michael B ^b   Rapp, Neville S ^b   Davis, Bernard B ^b  

^a Department of Pathology ^*  (United States)

^b GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; N [4 (5 NITRO 2 FURYL) 2 THIAZOLYL]FORMAMIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; BLADDER; BLADDER INJURY; CELL PROTECTION; ENZYME INHIBITION; MICROSOME;

ANIMALS; ASPIRIN; BIOTRANSFORMATION; CYCLOOXYGENASE INHIBITORS; FANFT; HYPERPLASIA; MALE; NEOPLASMS, EXPERIMENTAL; PROSTAGLANDINS E; RABBITS; RATS; THIAZOLES; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0019479834     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Brown, W. W., Zenser, T. V., and Davis, B. B., Prostaglandin E2 production by rabbit urinary bladder. Am. J. Physiol., 239: 1435–1440, 1980.
2. Cohen, S. M., Jacobs, J. B., Arai, M., Johansson, S., and Friedell, G. H., Early lesions in experimental bladder cancer: experimental design and light microscopic findings. Cancer Res. (Part 2, July), 36. 2508–2511, 1976.
3. Despopoulos, A., Renal metabolism of salicylate and salicylurate. Am. J. Physiol., 198: 230–232, 1960.
4. Elion, G. B., Yu, T.-F., Gutman, A. B., and Hitchings, G. H., Renal clearance of oxipurinol, the chief metabolite of allopurinol. Am. J. Med., 45: 69–77, 1968.
5. Flower, R. J., Drugs which inhibit prostaglandin biosynthesis. Pharmacol. Rev., 26. 33–67, 1974.
6. Fukushima, S., and Cohen, S. M., Saccharin-induced hyperplasia of the rat urinary bladder. Cancer Res., 40: 734–736, 1980.
7. Grundin, R., Jakobsson, S., and Cinti, D. L., Induction of microsomal aryl hydrocarbon (3,4-benzo(α)pyrene) hydroxylase and cytochrome P-450k in rat kidney cortex. I. Characteristics of the hydroxylase system. Arch. Biochem. Biophys., 158: 544–555. 1973.
8. Hamberg, M., and Samuelsson, B., On the specificity of the oxygenation of unsaturated fatty acids catalyzed by soybean lipoxidase. J. Biol. Chem., 242: 5329–5335, 1967.
9. Jacobs, J. B., Arai, M., Cohen, S. M., and Friedell, G. H., Early lesions in experimental bladder cancer: scanning electron microscopy of cell surface markers. Cancer Res., (Part 2, July), 36: 2512–2517, 1976.
10. Jacobs, J. B., Arai, M., Cohen, S. M., and Friedell, G. H., A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed A-[4-(5-nitro-2-furyl)-2-thiazolyl)formamide. Cancer Res., 37: 2817–2821, 1977.
11. Karmali, R. A., Prostaglandins and cancer. Prostaglandins Med., 5; 11–28, 1980.
12. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265–275, 1951.
13. Murasaki, G., and Cohen, S. M., Effect of dose of sodium saccharin on the induction of rat urinary bladder proliferation. Cancer Res., 41: 942–944, 1981.
14. Rapp, N. S., Zenser, T. V., Brown, W. W., and Davis, B. B., Metabolism of benzidine by a prostaglandin-mediated process in renal inner medullary slices. J. Pharmacol. Exp. Ther., 215: 401–406, 1980.
15. Rollins, T. E., and Smith, W. L., Subcellular localization of prostaglandin-forming cyclooxygenase in Swiss mouse 3T3 fibroblasts by electron microscopic immunocytochemistry. J. Biol. Chem., 255: 4872–4875, 1980.
16. Schenkman, J. B., Wilson, B. J., and Cinto, D. L., Dimethylaminoethyl 2,2-diphenylvalerate HCI (SKF 525-A)—in vivo and in vitro effects of metabolism by rat liver microsomes—formation of an oxygenated complex. Biochem. Pharmacol., 21: 2373–2383, 1972.
17. Steel, R. G. D., and Torrie, J. H., Principles and Procedures of Statistics, pp. 366–387. New York: McGraw-Hill Book Co., Inc., 1960.
18. Wang, C. Y., Behrens, B. C., Ichikawa, M., and Bryan, G. T., Nitroreduction of 5-nitrofuran derivatives by rat liver xanthine oxidase and reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase. Biochem. Pharmacol., 23. 3395–3404, 1974.
19. Wang, C. Y., and Bryan, G. T., Deacylation of carcinogenic 5-nitrofuran derivatives by mammalian tissues. Chem.-Biol. Interact., 9: 423–428, 1974.
20. Wang, C. Y., Hayashida, S., Pamukcu, A. M., and Bryan, G. T., Enhancing effect of allopurinol on the induction of bladder cancer in rats by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Cancer Res., 36: 1551–1555, 1976.
21. Zenser, T. V., Mattammal, M. B., Armbrecht, H. J., and Davis, B. B., Benzidine binding to nucleic acids mediated by the peroxidative activity of prostaglandin endoperoxide synthetase. Cancer Res. 40: 2839–2845, 1980.
22. Zenser, T. V., Mattammal, M. B., and Davis, B. B., Co-oxidate metabolism of 2-amino-4-(5-nitro-2-furyl-thiazole by prostaglandin hydroperoxidase. J. Lab. Clin. Med., 96. 425–432, 1980.
23. Zenser, T. V., Mattammal, M. B., and Davis, B. B., Metabolism of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide by prostaglandin endoperoxide synthetase. Cancer Res., 40: 114–118. 1980.